A Potential Mechanism of High-Dose Ticagrelor in Modulating Platelet Activity and Atherosclerosis Mediated by Thymic Stromal Lymphopoietin Receptor

Abnormal expression of thymic stromal lymphopoietin (TSLP) and its receptor (TSLPR) was found in patients with acute coronary syndrome. Ticagrelor, an oral platelet ADP P2Y12 receptor antagonist, is widely used in these patients. The aim of this study was to verify whether different doses of ticagre...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Mao, Yi, Peng, Yudong, Zeng, Qiutang, Cheng, Longxian, Wang, Boyuan, Mao, Xiaobo, Meng, Kai, Liu, Yuzhou, Lian, Yitian, Li, Dazhu
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2015
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4627752/
https://ncbi.nlm.nih.gov/pubmed/26517374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0141464
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires